» Authors » Mihalis I Panayiotidis

Mihalis I Panayiotidis

Explore the profile of Mihalis I Panayiotidis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 124
Citations 2718
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Theodoulou A, Speckmann T, Potamiti L, Baba O, Morita T, Drousiotou A, et al.
FEBS J . 2025 Feb; PMID: 40001216
Starch-binding domain-containing protein 1 (Stbd1) is a glycogen-binding protein which localizes to the endoplasmic reticulum (ER) membrane and ER-mitochondria contact sites (ERMCs). The protein undergoes N-myristoylation, which is a major...
2.
Ververis A, Kyriakou S, Paraskeva H, Panayiotidis M, Plioukas M, Christodoulou K
Int J Mol Sci . 2024 Dec; 25(23). PMID: 39684612
L., commonly known as eyebright, is a medicinal plant used in folk medicine for eye disorders and memory loss. Due to its abundance of compounds with proven neuroprotective properties, there...
3.
Tsochantaridis I, Brisimis D, Tsifintaris M, Anastasiadou A, Lazos E, Ermogenous A, et al.
Int J Mol Sci . 2024 Oct; 25(19). PMID: 39408636
Aldehyde dehydrogenases (ALDHs) constitute a diverse superfamily of NAD(P)-dependent enzymes pivotal in oxidizing endogenous and exogenous aldehydes to carboxylic acids. Beyond metabolic roles, ALDHs participate in essential biological processes, including...
4.
Vasileiadis A, Bozidis P, Konstantinidis K, Kesesidis N, Potamiti L, Kolliopoulou A, et al.
Curr Issues Mol Biol . 2024 Sep; 46(9):9312-9329. PMID: 39329903
Antibiotics resistance is expanding amongst pathogenic bacteria. Phage therapy is a revived concept for targeting bacteria with multiple antibiotics resistances. In the present study, we isolated and characterized a novel...
5.
Zanti M, OMahony D, Parsons M, Dorling L, Dennis J, Boddicker N, et al.
medRxiv . 2024 Sep; PMID: 39281752
Clinical genetic testing identifies variants causal for hereditary cancer, information that is used for risk assessment and clinical management. Unfortunately, some variants identified are of uncertain clinical significance (VUS), complicating...
6.
Davidson A, Michailidou K, Parsons M, Fortuno C, Bolla M, Wang Q, et al.
Am J Hum Genet . 2024 Aug; 111(9):2059-2069. PMID: 39096911
Co-observation of a gene variant with a pathogenic variant in another gene that explains the disease presentation has been designated as evidence against pathogenicity for commonly used variant classification guidelines....
7.
Tragkola V, Anestopoulos I, Kyriakou S, Amery T, Franco R, Pappa A, et al.
Toxicol Mech Methods . 2024 Jun; 34(9):985-999. PMID: 38919011
Malignant melanoma is the most aggressive type of skin cancer with increasing incidence rates worldwide. On the other hand, watercress is a rich source of phenethyl isothiocyanate (PEITC), among others,...
8.
Cherian Lukose C, Anestopoulos I, Panayiotidis M, Birkett M
ACS Biomater Sci Eng . 2024 Apr; 10(5):2935-2944. PMID: 38627890
Ti-Au intermetallic-based material systems are being extensively studied as next-generation thin film coatings to extend the lifetime of implant devices. These coatings are being developed for application to the articulating...
9.
Anestopoulos I, Paraskevaidis I, Kyriakou S, Giova L, Trafalis D, Botaitis S, et al.
Int J Mol Sci . 2024 Mar; 25(5). PMID: 38473991
In this study, we utilized an in vitro model consisting of human malignant melanoma as well as non-tumorigenic immortalized keratinocyte cells with the aim of characterizing the therapeutic effectiveness of...
10.
Orfanakos K, Alifieris C, Verigos E, Deligiorgi M, Verigos K, Panayiotidis M, et al.
Biomedicines . 2024 Jan; 12(1). PMID: 38255239
Ionizing radiation is strongly linked to direct or indirect DNA damage, as with the production of reactive oxygen species (ROS), which in turn produce DNA damage products, such as 8-hydroxy-2-deoxyguanosine...